We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+6.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$65.6B
AUM Growth
+$9.58B
Cap. Flow
+$6.37B
Cap. Flow %
9.71%
Top 10 Hldgs %
7.83%
Holding
4,198
New
794
Increased
1,441
Reduced
1,175
Closed
737

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$208M
2
CXO
CONCHO RESOURCES INC.
CXO
+$177M
3
CCI icon
Crown Castle
CCI
+$168M
4
WMT icon
Walmart Inc
WMT
+$167M
5
ETR icon
Entergy
ETR
+$157M

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 13.18%
3 Healthcare 11.51%
4 Industrials 10.45%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEAC
3426
DELISTED
Seachange International Inc
SEAC
$35K ﹤0.01%
630
-990
-61% -$53.4K
SNGX icon
3427
Soligenix
SNGX
$8.81M
$34K ﹤0.01%
+63
New +$33.7K
GERN icon
3428
Geron
GERN
$977M
$33K ﹤0.01%
15,116
-76,786
-84% -$181K
ARGS
3429
DELISTED
Argos Therapeutics, Inc.
ARGS
$32K ﹤0.01%
9,002
-663
-7% -$3.18K
ALIM
3430
DELISTED
Alimera Sciences
ALIM
$29K ﹤0.01%
1,454
-26
-2% -$556
BIOL
3431
DELISTED
Biolase, Inc.
BIOL
$29K ﹤0.01%
4
PFIE
3432
DELISTED
Profire Energy, Inc
PFIE
$28K ﹤0.01%
+14,065
New +$20.9K
BIOC
3433
DELISTED
Biocept, Inc.
BIOC
$28K ﹤0.01%
+3
New +$35.5K
ASM
3434
Avino Silver & Gold Mines
ASM
$1.25B
$27K ﹤0.01%
17,700
VIRX
3435
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$26K ﹤0.01%
383
ATIS
3436
DELISTED
Attis Industries Inc. Common Stock
ATIS
$25K ﹤0.01%
2,524
-1,100
-30% -$11.9K
NAVB
3437
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$25K ﹤0.01%
2,971
-12,293
-81% -$104K
SLS icon
3438
SELLAS Life Sciences
SLS
$2.89B
$24K ﹤0.01%
45
-30
-40% -$19.8K
WWR icon
3439
Westwater Resources
WWR
$74.5M
$24K ﹤0.01%
331
+116
+54% +$8.32K
XPL icon
3440
Solitario Resources
XPL
$75.1M
$22K ﹤0.01%
31,864
-46,598
-59% -$34.2K
SCON
3441
DELISTED
Superconductor Technologies Inc.
SCON
$22K ﹤0.01%
+213
New +$26.4K
MBOT icon
3442
Microbot Medical
MBOT
$99.4M
$21K ﹤0.01%
+1,178
New +$20.8K
LIQT icon
3443
LiqTech
LIQT
$19.8M
$20K ﹤0.01%
+1,691
New +$19.6K
XTIA icon
3444
XTI Aerospace
XTIA
$54.6M
0
LOV
3445
DELISTED
Spark Networks SE American Depositary Shares
LOV
$20K ﹤0.01%
+16,166
New +$17.3K
TBCH
3446
Turtle Beach Corp
TBCH
$225M
$19K ﹤0.01%
+5,656
New +$16.5K
BLPH
3447
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$18K ﹤0.01%
+860
New +$16K
PHIO icon
3448
Phio Pharmaceuticals
PHIO
$13.6M
$16K ﹤0.01%
+1
New +$34.5K
PTN
3449
Palatin Technologies
PTN
$18.1M
$16K ﹤0.01%
+19
New +$11.3K
CVM.WS
3450
DELISTED
Cel-Sci Corp Series S
CVM.WS
$16K ﹤0.01%
500,000

Similar funds

Israel Englander's Q3 2017 Portfolio in Review

As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.

  • Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
  • Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
  • Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
  • Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
  • Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
  • Israel Englander opened 794 new positions and closed 737 in Q3 2017.
  • Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.

Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.